New technique could one day be used to target glioblastoma

FHS
July 18, 2024
3:29 am

Tackling brain cancer is complicated, but groundbreaking new research could help add another tool to the cancer-fighting arsenal.

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab – Biotech Investments

EQS-News: Lindis Biotech GmbH / Key word(s): Agreement LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab 19.11.2024 / 10:07 CET/CEST The

November 20, 2024

New study identifies regional hotspots for Parkinson’s disease

A new study led by researchers at Barrow Neurological Institute has found that people living in regions with median levels of air pollution have a

October 31, 2023

Hims’ push into compounded GLP-1 drugs risks scrutiny from Novo Nordisk

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The digital health company Hims & Hers

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.